Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease: a Single-centre Observational Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2015
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Feb 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 08 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.